Marquis, L., & Mantel, I. (2020). Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol.
Styl cytowania ChicagoMarquis, Liza-Marie, i Irmela Mantel. "Beneficial Switch From Aflibercept to Ranibizumab for the Treatment of Refractory Neovascular Age-related Macular Degeneration." Graefes Arch Clin Exp Ophthalmol 2020.
Styl cytowania MLAMarquis, Liza-Marie, i Irmela Mantel. "Beneficial Switch From Aflibercept to Ranibizumab for the Treatment of Refractory Neovascular Age-related Macular Degeneration." Graefes Arch Clin Exp Ophthalmol 2020.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..